Year: 2020

Lending Leaders Positive About MeridianLink® Acquisition of Teledata Communications, Inc.

Written by Customer Service on November 12, 2020. Posted in Mergers And Acquisitions.

Costa Mesa, CA, Nov. 12, 2020 (GLOBE NEWSWIRE) — MeridianLink®, a leading provider of enterprise business solutions for financial service organizations, recently announced the acquisition of Teledata Communications, Inc. (TCI). TCI is the creator of DecisionLender, a SaaS loan origination solution (LOS) first released in 1998. DecisionLender is an industry-trusted LOS that serves more than 500 banks, credit unions, and financial companies nationwide.“The addition of TCI, which combines over 20 years of FinTech industry expertise and cutting-edge IP, will accelerate lending innovation,” said Christopher Maloof, chief product officer of MeridianLink. “We are thrilled to welcome a new addition to the MeridianLink family and expand our solutions line up in this rapidly evolving market.”MeridianLink will continue...

Monopar Therapeutics Reports Third Quarter 2020 Financial Results and Business Update

Written by Customer Service on November 12, 2020. Posted in Earnings Releases And Operating Results.

Validive®Phase 2b/3 Clinical Trial on Track to Start Before Year-endIssuance of New Patents For ValidiveCamsirubicin Phase 2 Clinical Trial to Start Late 2020/Early 2021WILMETTE, Ill., Nov. 12, 2020 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Monopar or the Company) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company primarily focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients, today announced third quarter 2020 financial results and business update.Third Quarter Business UpdateLead Product Candidate ValidiveMonopar’s Phase 2b/3 clinical trial of Validive (clonidine HCl mucobuccal tablet) for the prevention of severe oral mucositis (SOM) in patients undergoing chemoradiotherapy for oropharyngeal cancer (OPC) is on track to commence before year-end. There...

Todos Medical Announces $867,000 in Sales for October 2020

Written by Customer Service on November 12, 2020. Posted in Earnings Releases And Operating Results.

Sales primarily made up of extraction reagents Wisconsin client received request from State of Wisconsin to increase PCR testing by 200% Liquid handlers that increase capacity to 20,000 qPCR (4x of current capacity) tests per day delivered to Wisconsin client Wisconsin client per test revenue expected to increase 267% upon addition of qPCR kits to its weekly order in second half of November once liquid handler validation is completeNEW YORK, NY, REHOVAT, ISRAEL, SINGAPORE, Nov. 12, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Todos Medical (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease, today announced revenues for the month of October of $867,000, representing...

Zealand Pharma continues to advance clinical programs and commercial launch capabilities and presents financial results for the first nine months of 2020

Written by Customer Service on November 12, 2020. Posted in Public Companies.

Interim report for9M 2020Financial results for the first nine months of 2020Revenue: DKK 290.0 million / USD 45.6 million (DKK 29.8 million / USD 4.4 million in the first nine months of 2019).Net operating expenses: DKK -714.5 million / USD -112.3 million (DKK -431.5 million / USD -62.9 million in the first nine months of 2019).Net operating result: DKK -449.1 million / USD -70.6 million (DKK -402.1 million / USD -58.7 million in the first nine months of 2019).Cash, cash equivalents, and marketable securities: DKK 1,528.6 million / USD 240.4 million as of September 30, 2020 (September 30, 2019: DKK 1,543.2 million / USD 225.0 million).Business highlights for the third quarter of 2020 and subsequent eventsCompleted phase 1a single-ascending dose trial of ZP7570 (pINN: dapiglutide) for short bowel syndrome (SBS), demonstrating safety and...

Earth Alive Reports Third Quarter Results

Written by Customer Service on November 12, 2020. Posted in Earnings Releases And Operating Results.

MONTREAL, Nov. 12, 2020 (GLOBE NEWSWIRE) — Earth Alive Clean Technologies Inc. (TSXV: EAC) (“Earth Alive” or the “Company”), a Canadian soil health company that develops and manufactures advanced microbial technology products, this morning reported results for the third quarter ended September 30, 2020. All financial information is in Canadian dollars unless otherwise noted.Business HighlightsDuring the third quarter, four ea1™ trials were completed by Earth Alive customers in Brazil and Russia, with discussions towards commercialisation continuing with these customers.In August 2020, Earth Alive received confirmation from the California Department of Food & Agriculture that it has approved Soil Activator® for sale in the state and new distributors in California have already begun to place orders for our product.In September...

Wilhelmina International, Inc. Reports Results for Third Quarter 2020

Written by Customer Service on November 12, 2020. Posted in Earnings Releases And Operating Results.

Third Quarter Financial ResultsDALLAS, Nov. 12, 2020 (GLOBE NEWSWIRE) — Wilhelmina International, Inc. (Nasdaq:WHLM) (“Wilhelmina” or the “Company”) today reported revenues of $10.5 million and net income of $22 thousand for the three months ended September 30, 2020, compared to revenues of $17.2 million and net loss of $0.2 million for the three months ended September 30, 2019. For the nine months ended September 30, 2020, Wilhelmina reported revenues of $29.6 million and net loss of $5.3 million compared to revenue of $57.2 million and net income of $0.2 million for the nine months ended September 30, 2019. During the three and nine months of 2020, the novel coronavirus (COVID-19) pandemic had a material impact on revenues. The decrease in revenues when compared to the same periods of the prior year was...

Atreca Reports Third Quarter 2020 Financial Results and Recent Corporate Developments

Written by Customer Service on November 12, 2020. Posted in Earnings Releases And Operating Results.

SOUTH SAN FRANCISCO, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) — Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune response, today announced financial results for the third quarter ended September 30, 2020, and provided an overview of recent developments.“We continued to make progress enrolling patients and activating trial sites in our Phase 1b trial of ATRC-101 during the third quarter and anticipate reporting initial summary data in the first half of 2021,” said John Orwin, Chief Executive Officer. “We recently presented preclinical data at SITC 2020 further highlighting the potential for ATRC-101 as a combination therapy with checkpoint inhibitors targeting the PD-1/PD-L1...

FitLife Brands Announces Third Quarter 2020 Results

Written by Customer Service on November 12, 2020. Posted in Earnings Releases And Operating Results.

Omaha, Nov. 12, 2020 (GLOBE NEWSWIRE) — OMAHA, NE – November 12, 2020 — FitLife Brands, Inc. (“FitLife” or the “Company”) (OTC Pink: FTLF), an international provider of innovative and proprietary nutritional supplements for health-conscious consumers marketed under the brand names NDS Nutrition™, PMD®, SirenLabs®, CoreActive®, Metis Nutrition™, iSatori™, Energize, and BioGenetic Laboratories, today announced results for the three and nine months ended September 30, 2020.Highlights for the third quarter ended September 30, 2020 include:Total revenue increased 30% to $6.9 million compared to $5.3 million in the same quarter last year.Direct-to-consumer online sales increased 96% to $1.2 million, representing 17% of total revenue compared to 12% in the same quarter last year.Gross profit increased 27% to $2.9 million.Operating...

SPX Announces Purchase of Sensors & Software Inc.

Written by Customer Service on November 12, 2020. Posted in Mergers And Acquisitions.

CHARLOTTE, N.C., Nov. 12, 2020 (GLOBE NEWSWIRE) — SPX Corporation (NYSE:SPXC) today announced that it has completed the acquisition of Sensors & Software Inc. (“Sensors & Software”), based in Mississauga, Ontario. Sensors & Software is a manufacturer and distributor of Ground Penetrating Radar (GPR) products used for locating underground utilities, detecting unexploded ordinance, and geotechnical and geological investigations.“We are excited about Sensors & Software joining the SPX team,” said Gene Lowe, President and CEO of SPX Corporation. “Sensors & Software is a leader in GPR applications, with a strong brand, technology and user base that make it a highly complementary addition to our Radiodetection business’ industry-leading portfolio of cable and pipe locator and other detection and measurement products....

Nexans Press Release

Written by Customer Service on November 12, 2020. Posted in Mergers And Acquisitions.

Nexans Press ReleaseParis La Défense, November 12, 2020 – In response to the press release published earlier today by Cenergy Holdings of Greece, Nexans communicates that, in the context of its strategic review process, it engages with potential targets on a regular basis, including with Cenergy Holdings. The contacts with Cenergy Holding are at a preliminary stage. Further information will be disclosed as necessary.About NexansNexans is a key driver for the world’s transition to a more connected and sustainable energy future. For over 120 years, the Group has brought energy to life by providing customers with advanced cable technologies for power and data transmission. Today, Nexans goes beyond cables to offer customers a complete service that leverages digital technology to maximize the performance and efficiency of their critical assets....

Year: 2020

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals